Glucose
BLOOD AND BLOOD FORMING ORGANS
Also known as: (+)-Glucose, anhydrous dextrose, anhydrous glucose, D-Glucose, dextrose, dextrose monohydrate, glucose monohydrate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Glucose is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 1946. Recorded indications include Hypoglycemia.
- Approval status: ofp (first approved 1946 by the FDA).
- Indications: Hypoglycemia.
- ATC code: B05CX01 (Other irrigating solutions).
- Molecular formula: C6H12O6; molecular weight 180.16 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Hypoglycemia
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1946-01-17 | FDA | — | B BRAUN |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
B05CX01 | BLOOD AND BLOOD FORMING ORGANS › BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS › IRRIGATING SOLUTIONS › Other irrigating solutions |
C05BB56 | CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › ANTIVARICOSE THERAPY › Sclerosing agents for local injection |
V04CA02 | VARIOUS › DIAGNOSTIC AGENTS › OTHER DIAGNOSTIC AGENTS › Tests for diabetes |
V06DC01 | VARIOUS › GENERAL NUTRIENTS › OTHER NUTRIENTS › Carbohydrates |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Myelosuppression | 1497.4 |
| Pemphigus | 747.4 |
| Hypokalaemia | 716.9 |
| Hand deformity | 649.8 |
| Systemic lupus erythematosus | 640.8 |
| Glossodynia | 596.2 |
| Acute kidney injury | 520.1 |
| Hyperkalaemia | 512.6 |
| Cardiac failure congestive | 493.4 |
| Duodenal ulcer perforation | 475.6 |
| Helicobacter infection | 463.0 |
| Arthropathy | 461.3 |
Chemical structure
| Molecular formula | C6H12O6 |
|---|---|
| Molecular weight | 180.16 g/mol |
| CAS number | 492-61-5 |
| InChIKey | WQZGKKKJIJFFOK-VFUOTHLCSA-N |
| PubChem CID | 5793 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Glucose used for?
DrugCentral lists the following indications for Glucose: Hypoglycemia.
When was Glucose first approved?
Glucose was first approved by the FDA in 1946.
What is the chemical formula of Glucose?
Glucose has the molecular formula C6H12O6 and a molecular weight of 180.16 g/mol.
Browse: all drugs starting with G · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 845 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1222250 — compound record and bioactivity
- PubChem CID 5793 — chemical identifiers
- DrugBank DB01914 — drug record
- FDA UNII LX22YL083G — substance identity
- DailyMed: FDA labels for Glucose — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.